On Friday, Leerink Partners maintained a positive outlook on shares of Eli Lilly and Company (NYSE:LLY) shares, reiterating an Outperform rating and a price target of $950.00. The pharmaceutical giant ...

Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) – Research analysts at Leerink Partnrs issued their Q2 2025 earnings per share estimates for shares of Vir Biotechnology in a report released ...

Chef Chris Ponte is in the process of finalizing an agreement to expand Olivia and On Swann to University Town Center Sarasota, the largest shopping, dining and entertainment destination in the ...

In a report released on January 13, Faisal Khurshid from Leerink Partners reiterated a Buy rating on ANI Pharmaceuticals (ANIP – Research Report). The company’s shares closed yesterday at $54.16.

On Monday, Progyny (NASDAQ:PGNY) shares saw a change in their market prospects as Leerink Partners adjusted the company's price target. Analysts at Leerink Partners increased the price target on ...

In a report released on January 9, Thomas Smith from Leerink Partners reiterated a Buy rating on Climb Bio (CLYM – Research Report). The company’s shares closed last Friday at $2.00.

Leerink Partnrs also issued estimates for Geron’s Q3 2025 earnings at $0.01 EPS and Q4 2025 earnings at $0.02 EPS. Get Geron alerts: Geron ( NASDAQ:GERN – Get Free Report ) last announced its ...